Announcements Trials

Browse Landscape

Status

Active not recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Prostatic Neoplasms 1 Neoplasms, Germ Cell and Embryonal 1 Lung Neoplasms 1 Leukemia, Myeloid, Acute 1 Leukemia 1 HR+HER2- Advanced Breast Cancer 1 Glioblastoma 1 Disease 1 Carcinoma, Non-Small-Cell Lung 1 Advanced Gastric Cancer 1

Interventions

ribociclib 1 Drug Therapy, Combination 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

HR+HER2- Advanced Breast Cancer × Drug Therapy, Combination × Clear all

NCT06148506 2025-12-05

ValerEE

Novartis

Active not recruiting

HR+HER2- Advanced Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡